Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine as an adjuvant to ropivacaine for brachial plexus block
ChiCTR2100046233Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in arm injury and postoperative pain (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoints: Duration of analgesia and Time to loss of pain sensation. Started May 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
arm injurypostoperative pain
Beyond the preview
Go deeper on ChiCTR2100046233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046233.